-
Kenneth Thirstrup, PhD
… Molecular Biologist in the startup biotech company Display Systems Biotech, and later as project manager at Neurosearch …
-
Choosing a Deep Brain Stimulation Device
… the longest battery life of any available rechargeable DBS system. The battery is also the smallest of any system and has wireless charging. Other than the different … that made it the first adaptive, or self-adjusting, DBS system available for use. The Percept can adjust stimulation …
-
FDA Approves New DBS Device that Measures Brain Activity
June 30, 2020
… from implanted brain leads, combined with a patient diary system . This device allows us to measure and record brain … from other currently available DBS devices? JJS: Other DBS systems can deliver electricity through brain leads, but not … DBS devices . MJFF: How is it the same as other DBS systems? JJS: All available DBS devices contain the same …
-
Biospecimens
… specimens for PK and biomarker analysis were collected at multiple visits. The study was terminated after the … Colon Tissue Sub-Mandibular Gland Tissue See More S4 The Systemic Synuclein Sampling Study (S4) was a multicenter, … operating procedures for the collection and assessment of multiple tissues and biofluids to better understand …
-
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials for Parkinson’s and Related Diseases
September 9, 2024
… from the FDA also acknowledges the potential of a staging system for Parkinson’s and related diseases, specifically the first biological staging system known as the neuronal synuclein disease integrated staging system (NSD-ISS) . Early in 2024, a multistakeholder team …
-
IL-13Ra1 and Neuroinflammatory Damage in the MPTP Pre-Clinical Model of PD
… may represent novel therapeutic targets for PD. The "IL-13 system" is an attractive drug target due to its role in … here will help us determine whether targeting the "IL-13 system" represents a novel strategy to treat PD. Next Steps …